# FDA Inspection 1217689 - GeneXtend, LLC - September 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/genextend-llc/73998613-91c5-4132-a110-84df3288d026
Source feed: FDA_Inspections

> FDA Inspection 1217689 for GeneXtend, LLC on September 13, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217689
- Company Name: GeneXtend, LLC
- Inspection Date: 2023-09-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1217689 - 2023-09-13](https://www.keypedia.com/records/fda_inspections/genextend-llc/582dd0cf-f56d-49a3-a5f6-111ee6b59576)
- [FDA Inspection 1062807 - 2018-08-17](https://www.keypedia.com/records/fda_inspections/genextend-llc/ddaed345-a1ec-4042-93bf-ad693ec786ec)
- [FDA Inspection 1062807 - 2018-08-17](https://www.keypedia.com/records/fda_inspections/genextend-llc/c3940175-50d5-4b4b-8bc1-62320e437118)

Company: https://www.keypedia.com/companies/genextend-llc/efa8624c-2ecb-4d56-804e-f40847f55404

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d